Related by context. All words. (Click for frequent words.) 69 anti angiogenesis 68 MEK inhibitors 67 proteasome inhibitors 67 VEGF vascular endothelial 66 VEGF inhibitors 66 pro angiogenic 66 molecularly targeted 66 anticancer agents 65 beta adrenergic 65 SERMs 65 angiogenesis inhibitor 65 HCV protease inhibitors 65 antiangiogenic 65 PI3K/mTOR 65 TNF tumor necrosis 64 anticancer therapy 64 immune modulators 64 Panzem R 64 hedgehog pathway 64 PARP inhibitors 64 EGFR inhibitors 64 proteasome inhibitor 64 vascular disrupting agents 64 tyrosine kinase inhibitor 64 insulin sensitizers 64 multitargeted 64 endothelin receptor antagonists 64 Pertuzumab 64 gastrin 64 VEGF receptor 63 protein kinase inhibitors 63 inhibiting tumor 63 Dasatinib 63 mTOR inhibitors 63 tyrosine kinase inhibitors 63 insulin sensitizing 63 uric acid lowering 63 ixabepilone 63 PEG SN# 63 immunomodulatory 63 Factor VIIa 63 Abiraterone 63 HDAC inhibitors 63 lapatinib Tykerb 63 kinase inhibitors 63 thalidomide Thalomid 63 macrolide antibiotics 63 LY# [003] 63 Hedgehog signaling pathway 63 pertuzumab 62 gamma secretase inhibitor 62 PARP inhibitor 62 cediranib 62 Aurora Kinase 62 JAK3 62 BAY #-# 62 CTLA 4 62 CCR5 antagonists 62 HuLuc# 62 cancer immunotherapy 62 Crizotinib 62 histone deacetylase inhibitors 62 delta isoform 62 visilizumab 62 PI3K/Akt pathway inhibitor 62 Trastuzumab 62 Dapagliflozin 62 histone deacetylase HDAC inhibitors 62 glucagon receptor 62 CCX# 62 selective estrogen receptor 62 Zolinza 62 Panzem 62 CDDO Im 62 anticancer therapies 62 Smac mimetic 62 Tumor Necrosis Factor 61 AEG# 61 HER1 61 CCR2 61 Squalamine 61 enzyme inhibitors 61 direct thrombin inhibitors 61 CB1 antagonists 61 inhibiting angiogenesis 61 PI3 kinase 61 Panzem R NCD 61 darapladib 61 Vascular Endothelial Growth 61 vascular endothelial growth 61 YONDELIS 61 cancer immunotherapies 61 olmesartan 61 nucleoside analogs 61 pan HDAC inhibitor 61 calcium channel 61 PI3K inhibitors 61 deacetylase inhibitors 61 TELINTRA 61 MEK inhibitor 61 JAK inhibitors 61 mimetics 61 investigational therapies 61 NF kB pathway 61 gamma secretase inhibitors 61 chemopreventive agents 61 beta interferons 61 TNF á 61 CD# antibodies 61 epothilones 61 imatinib Gleevec 61 CYT# potent vascular disrupting 61 TNF alpha antagonist 61 Vaprisol 61 Bevacizumab 61 epigenetic therapies 61 CBLC# 61 histone deacetylase HDAC 61 anti angiogenic agents 61 Bortezomib 61 cilengitide 61 antiproliferative effects 61 factor Xa 61 antimetabolites 61 Talabostat 61 CA4P 61 cyclooxygenase 61 bortezomib Velcade 61 Atrasentan 61 cytoprotective 61 angiogenesis inhibition 60 protease inhibitors 60 selectively inhibit 60 PXD# 60 selective inhibition 60 Ridaforolimus 60 Nexavar ® 60 antiinflammatory 60 Factor Xa inhibitor 60 Vandetanib 60 EGFR pathway 60 DFMO 60 blockers angiogenesis inhibitors 60 IMC A# 60 LNP formulations 60 Factor Xa 60 mTOR kinase 60 Muraglitazar 60 pomalidomide 60 telomerase inhibitors 60 immune modulator 60 immunomodulator 60 Velcade bortezomib 60 cholinesterase inhibitors 60 Neuvenge 60 integrase inhibitors 60 Zybrestat 60 Mipomersen 60 erlotinib Tarceva 60 nucleoside analogues 60 echinocandins 60 Exelixis XL# 60 Symadex 60 receptor tyrosine kinase inhibitor 60 modulators SERMs 60 JAK inhibitor 60 BRAF inhibitor 60 hypoxia inducible factor 60 #ME# 60 cangrelor 60 Protease inhibitors 60 Elotuzumab 60 TNFα 60 selective androgen receptor modulators 60 prescribed proton pump 60 Leukine ® 60 novel peptide 60 Onconase 60 dasatinib Sprycel 60 Angiolix 60 Th2 cytokines 60 biologic therapies 60 Interferon alpha 60 siRNA therapeutics 60 interferon IFN 60 Deforolimus 60 tubulin inhibitor 60 Gefitinib 60 kinase inhibitor 60 orally administered inhibitor 60 immunotoxins 60 RANK ligand 60 Bisphosphonates 60 serotonin receptor 60 alkylating agent 60 DCVax R 60 kidney urologic 60 IAP inhibitors 60 anticancer drugs 60 selective modulator 60 idarubicin 60 EGFr 60 Hedgehog pathway 60 microtubule targeting 60 inhibit EGFR 60 antidiabetic 60 peptibody 60 beta blockers calcium 60 proton pump inhibitors PPIs 60 deforolimus 60 endostatin 60 antimetastatic 60 angiotensin receptor blockers 60 colony stimulating factors 59 anti angiogenic drugs 59 Tarvacin 59 Fibrates 59 SGLT 2 59 antidepressants SSRIs 59 investigational humanized monoclonal antibody 59 midstage clinical 59 SCH # 59 MEK ERK 59 regorafenib 59 anti angiogenic 59 targeted radiotherapeutic 59 Darapladib 59 Xanafide 59 AChE inhibitors 59 IGF 1R 59 immune modulating 59 neuraminidase inhibitors 59 cyclooxygenase 2 59 therapeutic peptide 59 COX enzymes 59 Anti angiogenic 59 S#P# 59 Vidofludimus 59 GW# [003] 59 CTLA4 Ig 59 incretin 59 HepDirect 59 signal transduction inhibitor 59 BRAF inhibitors 59 GRN#L 59 epothilone 59 PDE4 inhibitor 59 E2F Decoy 59 chimeric monoclonal antibody 59 TLR agonists 59 bevacizumab Avastin 59 factor VIIa 59 cytotoxics 59 anti VEGF 59 antiplatelet therapies 59 biologic therapeutics 59 investigational compounds 59 Elvitegravir 59 Nanobody 59 Aliskiren 59 antisense oligonucleotides 59 BRAF kinase 59 Epothilones 59 Enzastaurin 59 VEGF 59 inhibit vascular endothelial 59 JAK1 59 Cetrorelix 59 trastuzumab Herceptin 59 P#X# 59 CORT # 59 EGF receptor 59 phosphodiesterase inhibitors 59 histone deacetylase inhibitor 59 mapatumumab 59 CD# antibody [001] 59 enzastaurin 59 erlotinib Tarceva ® 59 OXi# 59 selective estrogen receptor modulators 59 olaparib 59 TRAIL receptor antibodies 59 A3 adenosine receptor 59 FLT3 59 PNP inhibitor 59 antiepileptics 59 CINOD 59 anti angiogenic therapies 59 calcineurin inhibitors 59 antitumoral 59 melanocortin receptor agonists 59 sorafenib tablets 59 anticlotting 59 trastuzumab DM1 59 Tyrima 59 TNFa 59 HGS# 59 PKCi 59 metaglidasen 59 laropiprant 59 Leukine 59 triglyceride lowering 59 chemopreventive 59 antiobesity 59 inhibit angiogenesis 59 C5a 59 mTOR mammalian target 59 perampanel 59 potent anticancer 59 oral prodrug 59 PORxin TM 59 TLR9 agonist 59 peroxisome proliferator activated 59 GSK3B 59 integrase inhibitor 59 PSN# [002] 59 IL# PE#QQR 59 infliximab Remicade 59 angiotensin receptor blocker ARB 59 polymerase inhibitors 59 HSP# inhibitor 59 ACZ# 59 Herceptin trastuzumab 59 chemopreventive agent 59 VEGF receptors 59 bone metastasis 59 antiarrhythmic 59 5 lipoxygenase 59 sphingosine kinase 58 eprotirome 58 peripherally acting 58 Rimonabant 58 Starlix 58 Notch pathway 58 SomatoKine 58 Amrubicin 58 DPP4 inhibitor 58 FGFR 58 antiangiogenic drugs 58 Bisphosphonate 58 azoles 58 adoptive immunotherapy 58 anticancer compound 58 receptor antagonists 58 mertansine 58 talabostat 58 Relovair 58 Carfilzomib 58 factor Xa inhibitors 58 THR beta agonist 58 Maribavir 58 HDACi 58 anti fibrotic 58 CYC# 58 histone deacetylases 58 mitochondrial toxicity 58 Tß4 58 Vectibix panitumumab 58 sargramostim 58 PKC# 58 humanized monoclonal antibody 58 receptors EGFR 58 renin inhibitors 58 liposomal formulation 58 Novartis Gleevec 58 PLX# 58 taxol 58 fenretinide 58 PPARgamma 58 HIV integrase inhibitor 58 vascular disrupting agent 58 SGS# 58 BZL# 58 ALN PCS 58 Eraxis 58 SGLT2 58 adalimumab Humira 58 anticancer 58 investigational monoclonal antibody 58 HMG CoA reductase inhibitors 58 thromboembolic disease 58 inhibit metastasis 58 taxanes 58 atrasentan 58 sodium glucose cotransporter 58 Calcitonin 58 Curaxin CBLC# 58 Aflibercept 58 AEGR 58 LRP5 58 anti CD3 58 thrombopoietin 58 tumor necrosis factor 58 virotherapy 58 inhibit tumor 58 Temsirolimus 58 CoFactor 58 nicotinic acetylcholine receptor 58 cholesterol absorption 58 TLR antagonists 58 JAK2 inhibitor 58 chemically modified siRNA 58 Imprime PGG 58 apoptosis inducing 58 Abiraterone acetate 58 Perifosine 58 TNF α 58 PPARγ 58 vorinostat 58 FBPase 58 Ontak 58 raltegravir 58 neratinib 58 protein tyrosine phosphatase 1B 58 thiazolidinediones 58 Epidermal Growth Factor Receptor 58 granulocyte colony stimulating 58 OHR/AVR# 58 potent inhibitors 58 antifibrotic 58 paclitaxel Taxol 58 acetylcholinesterase AChE 58 interferons 58 suppresses tumor 58 panobinostat 58 flavopiridol 58 Amplimexon 58 ENMD # 58 Erlotinib 58 mGluR5 antagonist 58 Ipilimumab 58 cholesteryl ester transfer 58 PI3K inhibitor 58 multi kinase inhibitor 58 demethylating agents 58 PDE7 58 pediatric malignancies 58 leukotriene pathway 58 TBC# 58 Homspera TM 58 LTB4 58 menadione 58 GRN# 58 iniparib 58 HCV protease inhibitor 58 trans retinoic acid 58 sulfonylureas 58 Galectins 58 immune modulation 58 Everolimus 58 immunosuppressive 58 hormone gastrin 58 aspirin clopidogrel 58 leukotriene receptor antagonist 58 gefitinib Iressa 58 HDAC 58 aromatase inhibitors AIs 58 HDACs 58 MGCD# [001] 58 motesanib 58 Boceprevir 58 nicotinic acid 58 TNF inhibitors 58 Neulasta ® 58 Maraviroc 58 DU #b 58 leukotrienes 58 GnRH agonists 58 BCR ABL inhibitors 58 VEGF Trap 58 immune modulatory 58 mTOR inhibitor 58 LHRH agonists 58 #beta HSD1 58 mutated KRAS gene 58 triterpenoids 58 Aurora kinase 58 abiraterone 58 NFkB 58 receptor inhibitor 58 LY# [002] 58 TLR9 agonists 58 antisense oligonucleotide 58 ARRY # 58 TriRima 58 serotonin reuptake 58 non peptidic protease 58 forodesine 58 tubulin binding 58 mda 7 58 enzyme inhibitor 58 Icatibant 58 Archexin 58 synthetic retinoid 57 Bruton tyrosine kinase Btk 57 dipeptidyl peptidase IV 57 eltrombopag 57 Vorinostat 57 INC# 57 GSK# [002] 57 ISTODAX 57 rituximab Rituxan 57 Arranon 57 renoprotective 57 Omacetaxine 57 Allovectin 7 57 Sudhir Agrawal D.Phil 57 IgG1 monoclonal antibody 57 Degarelix 57 Noxafil 57 Celebrex celecoxib 57 itraconazole 57 engineered RAP peptides 57 Torisel 57 preclinically 57 calcium antagonists 57 Exemestane 57 Factor Receptor 57 FGFs 57 HCV replication 57 MAXY G# 57 angiotensin receptor 57 ErbB3 HER3 57 isoform selective 57 glitazones 57 anticancer compounds 57 neuroprotection 57 Bezielle 57 Janus kinase 57 neuro protective 57 adrenal hormone 57 cytostatic 57 cannabinoid receptor 57 Pimavanserin 57 potent antiproliferative 57 aprepitant 57 Interferon beta 57 radionuclide therapy 57 reslizumab 57 PSMA ADC 57 osteoclast activity 57 interleukins 57 antibody MAb 57 AT1R 57 ALK inhibitors 57 LHRH antagonists 57 Vilazodone 57 PI3K 57 PHD2 57 glatiramer 57 small molecule tyrosine 57 PPAR gamma agonists 57 Nexavar sorafenib 57 selective androgen receptor modulator 57 INT# [002] 57 immunomodulating 57 dexrazoxane 57 decitabine 57 TÎ ² 4 57 Ticagrelor 57 etidronate 57 immuno modulatory 57 anakinra 57 tarenflurbil 57 sapacitabine 57 IMiDs ® 57 signal transduction inhibitors 57 COX 2 57 anticancer agent 57 oral antiplatelet 57 agonist compounds 57 Nanobody ® 57 targeted antifolate 57 CXCR4 receptor 57 VEGF pathway 57 cyclin dependent kinases 57 temsirolimus 57 Survivin 57 immunomodulation 57 Sphingomab 57 mitotic kinesins 57 nalbuphine ER 57 Smac mimetics 57 rhIL 7 57 MMP inhibitors 57 Novartis Zometa 57 Sorafenib 57 G CSF 57 Valproic acid 57 adrenergic receptors 57 Pemetrexed 57 lipid lowering agents 57 Cytoxan 57 nicotinic alpha 7 57 Hsp# inhibitors 57 bevacizumab Avastin ® 57 PI3K Akt 57 Tasimelteon 57 basic fibroblast 57 NNRTIs 57 PLK1 SNALP 57 ADP receptor antagonist 57 oxidative stress inducer 57 vascular disrupting 57 chemotherapeutic agents 57 Insegia 57 resolvins 57 RAF kinase 57 pegylated liposomal doxorubicin 57 MAGE A3 ASCI 57 angiogenesis 57 Valsartan 57 novel immunomodulatory 57 IGFBP2 57 Litx 57 Atiprimod 57 Vicriviroc 57 Golimumab 57 davalintide 57 reversible inhibitor 57 tumor subtypes 57 endothelin receptor 57 obatoclax 57 Modrenal 57 OMP #M# 57 DHFR 57 Antiangiogenic 57 Targretin 57 antithrombotic 57 histone deacetylase HDAC inhibitor 57 gemcitabine Gemzar 57 Pralatrexate 57 vivo validation 57 Solazed TM 57 muscarinic 57 IMiDs R 57 Vascular endothelial growth 57 hypoxic tumors 57 antisense drug 57 vinca alkaloid 57 retinoids 57 Cisplatin 57 carbohydrate polymers 57 antiemetics 57 TNFalpha 57 Sapacitabine 57 tamoxifen Nolvadex ® 57 Nuvion 57 NRTIs 57 Glufosfamide 57 pharmacologic agents 57 Taxol paclitaxel 57 humanized antibody 57 Avanafil 57 PRT# 57 chemokine receptor 57 Gleevec resistant 57 prostaglandin D2 57 GPCR targets 57 sPLA2 57 paclitaxel Taxol ® 57 Telintra 57 incretin mimetics 57 antimetabolite 57 mTOR inhibition 57 humanized monoclonal antibodies 57 Cobalamin 57 prostaglandin synthesis 57 NXL# 57 Gemzar ® 57 sirolimus 57 brostallicin 57 PrevOnco 57 macrophage colony stimulating 57 BEXXAR Therapeutic Regimen 57 receptor agonists 57 Preclinical studies suggest 57 neuroprotectant 57 rNAPc2 57 sulindac 57 VAPRISOL 57 Cerashield 57 EGFR tyrosine kinase inhibitors 57 neuroprotective 57 anti angiogenic therapy 57 EndoTAG TM -1 57 R sorafenib tablets 57 MNTX 57 axitinib 57 Lodamin 57 Tissue Factor 57 PDE4 inhibitors 57 humanised monoclonal antibody 57 heparins 57 antiplatelet agent 57 luteinizing hormone releasing 57 gastrointestinal stromal tumors 57 NKT cells 57 costimulation 57 Aurora kinase inhibitor 57 Gamma secretase 57 Apixaban 57 GAP #B# 57 COX2 57 ZD# [001] 57 substrates inhibitors 57 LHRH 57 inhibiting COX 57 raloxifene Evista 57 6R BH4 57 ovarian breast 57 TGF beta 57 HSP# inhibitors 57 erythropoietic 57 HuMax EGFr 57 protein kinase inhibitor 57 anti androgen 57 NF kappa B 56 immunotherapeutic vaccine 56 antiapoptotic 56 cardiometabolic disorders 56 highly selective inhibitor 56 Celecoxib 56 ZOLINZA 56 figitumumab 56 NS5A 56 oral Factor Xa 56 GSK3 56 NV1FGF 56 IAP inhibitor 56 M2 subunit 56 renin angiotensin aldosterone 56 Proxinium TM 56 Genentech Herceptin 56 solid organ transplantation 56 neurotrophic 56 thromboxane A2 56 protein kinase C 56 aromatase inhibitors 56 intracellular signaling pathways 56 Revlimid lenalidomide 56 MYDICAR ® 56 immunostimulatory 56 thiazolides 56 muraglitazar 56 GVAX 56 PDGF receptor 56 antiandrogen 56 drug conjugate 56 Elesclomol 56 Teriflunomide 56 PDE# 56 RNAi therapeutic targeting 56 LPA1 56 dacetuzumab 56 AKT inhibitor 56 Eltrombopag 56 TYZEKA 56 Fenretinide 56 anticancer treatments 56 antisense 56 huC# DM4 56 novel topoisomerase 56 HDAC inhibition 56 angiotensin converting enzyme inhibitors 56 pramlintide metreleptin combination 56 Nonsteroidal anti inflammatory 56 poly ADP ribose polymerase 56 Known generically 56 pharmacokinetic interactions 56 bone morphogenetic proteins 56 prostanoid 56 histone deacetylase 56 molecularly targeted therapy 56 inhibitor rofecoxib 56 1 receptor IGF 56 vildagliptin 56 Cloretazine VNP#M 56 HGS ETR1 56 Axitinib 56 Camptothecin 56 vasodilators 56 TACI Ig 56 Reverset 56 novel VDA molecule 56 plasmid DNA vaccine 56 HIV protease inhibitors 56 investigational protease inhibitor 56 thiazolidinediones TZDs 56 Afatinib 56 telomerase activation 56 IFNs 56 therapeutic monoclonal antibody 56 HCV protease 56 GDIR 56 Vitaxin 56 humanized monoclonal 56 protein mTOR 56 NEUGENE 56 Eculizumab 56 microtubule inhibitor 56 histone methyltransferases HMTs 56 novel peptides 56 OvaRex ® MAb 56 ORENCIA R 56 coagulation cascade 56 panitumumab Vectibix 56 Immunotherapeutic 56 myelofibrosis polycythemia vera 56 conjugated estrogen 56 small molecule agonists 56 ACE Inhibitors 56 immunotoxin 56 R#/MEM # 56 Omalizumab 56 paroxetine Paxil 56 DXL# 56 Virulizin ® 56 PDGFR 56 Cancidas 56 antiangiogenesis 56 IGF IR 56 CRx 56 PROCHYMAL 56 INCB# [001] 56 HQK 56 elotuzumab 56 5 HT2A inverse 56 Alemtuzumab 56 Ceflatonin R 56 DNA intercalator 56 Panzem NCD 56 Affinitak 56 Ad5FGF 4 56 antisense inhibition 56 Xelox 56 TNF alpha inhibitors 56 oral anticoagulants 56 RhuDex ® 56 Silodosin 56 immunosuppressive agents 56 cytotoxic therapies 56 small molecule inhibitors 56 ALN VSP 56 fingolimod 56 ERK pathway 56 RELOVAIR ™ 56 PEGylated interferon 56 rolipram 56 ACE inhibitors angiotensin receptor 56 siRNA therapeutic 56 antimitotic 56 trastuzumab DM1 T DM1 56 PEG Interferon lambda 56 Curaxin 56 LPA1 receptor 56 TGF ß 56 CCR9 56 Panitumumab 56 hematological indications 56 tremelimumab 56 potent inhibitor 56 metastatic colorectal 56 CIPN 56 Dalbavancin 56 inhibitors 56 Doxil 56 Diamyd ® 56 otelixizumab 56 angiotensin II receptor blocker 56 antiproliferative 56 5 HT6 receptor 56 goserelin 56 RANKL 56 serine protease 56 aromatase 56 thymidylate synthase 56 adenosine A2A 56 serine proteases 56 anti CD# antibodies 56 IDH1 56 Enkephalin 56 p# inhibitors 56 Phase IIb clinical trials 56 Benign Prostatic Hyperplasia 56 sorafenib Nexavar 56 rxRNA 56 canagliflozin 56 immunotherapeutic agent 56 Pazopanib 56 anticholinergic agents 56 mecamylamine 56 tranilast 56 Voreloxin 56 sunitinib malate 56 standard chemotherapy regimens 56 agonists antagonists 56 5 HT2A receptor 56 highly selective endothelin 56 CR# vcMMAE 56 quinolones 56 Bendavia 56 HIV integrase inhibitors 56 benign prostatic hypertrophy BPH 56 Hepatocellular Carcinoma HCC 56 clinically validated targets 56 lanreotide 56 PI3K/Akt pathway 56 Pradefovir 56 NeuroVax TM 56 ReoPro 56 immunotherapy 56 anti angiogenic agent 56 antiplatelet drugs 56 Telaprevir 56 alpha interferon 56 XmAb# 56 AMN# [001] 56 Ixabepilone 56 thrombin receptor 56 Rigel R# 56 Ceflatonin 56 JAK2 enzyme 56 anticholinergics 56 RGB # 56 interferon beta 56 RNA antagonists 56 TOCOSOL Camptothecin 56 senicapoc 56 chemoprevention 56 rhThrombin 56 androgen hormone 56 Arcalyst 56 docetaxel Taxotere ® 56 Raltegravir 56 antitumor effect 56 antithrombotics 56 postmenopausal hormone 56 anticancer therapeutics 56 selective agonists 56 ocrelizumab 56 fenofibric acid 56 diabetic kidney 56 letrozole Femara 56 PEGPH# 56 IGF1R 56 protein tyrosine phosphatases 56 antihormonal 56 diarrhea predominant irritable 56 elvitegravir 56 cardio renal 56 doxorubicin Adriamycin 56 SNT MC# 56 cardiac glycosides 56 interleukin 56 Adnectin 56 Fludarabine 56 bexarotene 56 TG# [003] 56 Blinatumomab 56 antiangiogenic therapy 56 TREANDA 56 OncoVEX GM CSF 56 radiotherapeutic 56 targeted biologic therapies 56 cardiotoxic 56 immunoconjugate 56 Tesetaxel 56 imatinib Gleevec ® 56 oncolytic 56 Inhalation Solution 56 docetaxel Taxotere R 56 Cabazitaxel 56 Vidaza azacitidine 56 pancreatic prostate 56 anidulafungin 56 PANVAC VF 56 nucleoside analogue 56 CFTR inhibitors 56 PlGF 56 teplizumab 56 HER2 receptor 56 antidiabetic drugs 56 Epivir 56 H2 blockers 56 antifungal agents 56 AQ4N 56 Angiotensin Converting Enzyme 56 vWF 56 secondary hyperparathyroidism 56 CETP inhibitors 56 Leuprolide 56 angiotensin II receptor antagonists 56 TNF Tumor Necrosis Factor 56 immune stimulatory 56 androgens 56 oxysterols 56 CYP#A# inhibitors 56 oncomodulin